The point of care concept is at a crossroads: the technologies needed to make rapid testing a reality are here. But is healthcare ready?

The drive for wellness and the attention surrounding healthcare reform will surely focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to fit, and those companies willing to pivot strategies and best adjust to changes in the healthcare marketplace may be rewarded.

This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role of Point of Care Diagnostics in today's in vitro industry. Other reports have looked at products, companies and market forecasts, as this report does. This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. The report includes:

- Markets for POC Diagnostics (Diabetes, Cardiac markers, Clinical Chemistry/Critical Care, Hematology, Coagulation, Drugs of Abuse/Therapeutic Drug Monitoring, Infectious Diseases, Pharmacodiagnostics, Sepsis, Oncology, Women's health / Pregnancy/Fertility)
- By Venue Revenue Estimates for Hospital POC, Physician POC and Other Venue
- Review of Products in the Market
- Forecasts to 2013
- Markets and Forecasts for Self-Testing (OTC)
- The role of EMR in the Point of Care Market
-Possible Effects of Healthcare Reform
- POLs, Home Monitoring, Alternate Samples and Other Trends
- Successful Strategies of POC Companies

Profiles of Over 100 Companies Competing in this Market

There are many factors in the growth of POC testing- increasing numbers of diagnosed diabetics, people with cardiovascular disease, and other chronic conditions. It is also expected to play a role in a trend in health care to evaluate provider organizations for quality in care delivery. While this quality imperative is most apparent in pay-for-performance systems, it also provides a framework by which public funds can be used more rationally. This is an especially relevant technology given the U.S. healthcare reform efforts.

All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.

The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.

The following companies are discussed:

-23andMe
-3M Health Care
-77 Elektronika
-A. Menarini
-A/C Diagnostics
-Abaxis, Inc.
-Abbott Diagnostics
-ABTECH Scientific
-Accumetrics
-ACIST Medical
-Acrongenomics Inc.
-Adeza Biomedical
-ADIATEC
-Aerscher Diagnostics
-AgaMetrix, Inc.
-Alfa Scientific
-Alfa Wassermann
-Alverix Inc.
-American Bio Medica
-Amic/Ortho
-Amnisure International
-Animas/J&J
-ANP Technologies
-Antigen Discovery Inc.
-Apollo Hospitals
-Arkray
-Arrayit Diagnostics
-AspenBio Pharma
-Astron Clinica
-AT First Diagnostic
-Audit Diagnostics
-Axis-Shield plc
-Bayer Diabetes Care
-Beckman Coulter
-Becton Dickinson
-Bedfont Scientific
-Biohit Oy
-BioIQ
-bioLytical Labs
-Biomagnetics Diagnostics
-Biomerica, Inc.
-bioMérieux
-Bionime Corp.
-Bio-Rad Laboratories
-BIOSAFE Medical Technologies
-Biosite/Inverness
-Boditech Med
-BodyTel Scientific
-Branan Medical Corp
-Burnet Institute
-Calypte Biomedical
-Careside Medical
-Carolina Liquid Chemistries
-Celerus Diagnostics
-Chelsea Technologies
-Chembio Diagnostic
-Chempaq A/S
-Chemtron Biotech
-Cholestech Corp.
-Claros Diagnostics
-CLX Medical, Inc.
-Combimatrix
-Common Sense, Ltd.
-Commonwealth Labs
-Connectyx Technologies
-ContraVac, Inc.
-Decision Biomarkers
-DexCom, Inc.
-Diabetech, LP
-Diabetes Sentry
-Diaglobal GmbH
-Diagnostic Devices
-Diagnostics for All
-Diagnostics for the Real World
-Diazyme Laboratories
-Digital Bio Tech
-Diversa Limited
-DNA Direct, Inc.
-DNAFORM
-DxNA
-Echo Therapeutics
-EKF-diagnostic GmbH
-Enfora
-Enigma Diagnostics
-Enterix Inc.
-Entra Health
-Epocal, Inc.
-EPS Bio Technology
-ESA Biosciences
-eScreen, Inc.
-ExpressMD Solutions
-EyeMarker Systems
-Flexsite Diagnostics
-Focus Diagnostics
-Fora Care
-GE Healthcare
-GenBio
-Gene Smart Wellness
-Genexel-Sein Inc.
-Gentag Inc.
-Genzyme Diagnostics
-Global Detection & Reporting
-Glucometrics, Inc.
-Google, Inc.
-Guided Therapeutics
-Hai Kang Life Corp.
-Hain Lifescience GmbH
-HandyLab, Inc.
-HealthPia America
-HealthPort
-Helena Laboratories
-Hema Diagnostic Systems
-Hema Metrics
-HemoCue AB
-Hero Network Network
-HMM GmbH
-Hoana Medical
-Home Access Health
-Home Diagnostics
-Horiba ABX
-Idaho Technology
-IDenta Corp
-Identigene
-IDEXX Laboratories
-incentaHEALTH LLC
-Innovative Biosensors
-Instrumentation Laboratory
-Insulet Corporation
-Integrity Applications
-Intel Corporation
-International Technidyne
-Inverness Medical Innovations
-Knome
-Lab Express
-LifeAssays AB
-Lifescan
-LifeSign LLC
-LifeStat
-Lifestream Technologies, Inc.
-Lifestyle Choices
-Luminex
-Luminous Medical
-MACHEREY-NAGEL
-Masimo Corp
-Matritech
-M-Biotech
-Medical Automation Systems
-MedMira Inc.
-Medtronic Inc.
-Menssana Research, Inc.
-Meretek Diagnostics Inc.
-Meridian Bioscience
-Micromem Technologies
-Micronics Inc.
-MicroPhage, Inc.
-MinuteClinic
-Mitsubishi Kagaku Iatron
-MP Biomedicals
-Multilyte Limited
-MycroLab Pty
-Nanogen
-Nanomix, Inc.
-Nanosphere, Inc.
-National Jewish Health
-Navigenics, Inc.
-Network Biosystems
-Neuroptix Corp
-Nihon Kohden
-Noninvasive Medical Tech
-Nova Biomedical
-OPTI Medical Systems
-OraSure Technologies
-Orion Diagnostica
-OrSense Ltd.
-Ortho Clinical Diagnostics
-OvumOptics, Inc.
-Oxford Biosensors
-Oxonica Diagnostics
-Phadia AB
-Philips Handheld Immunoassays
-PlaCor, Inc.
-PointCare Technologies
-Polymedco
-Practice Fusion
-PreMD Inc.
-PrimeraDx
-Probe Scientific Ltd
-Prometheus Laboratories
-Psynomics
-QBC Diagnostics
-Qiagen
-Q-linea
-Quadraspec
-QualSec, Inc
-QuantRx Biomedical Corporation
-Quidel Corp
-Quotient Diagnostics
-Radiometer A/S
-Raman spectroscopy
-Rapid Pathogen Screening
-Rennesens GmbH
-Response Biomedical
-Rite Aid
-Roche Diagnostics
-Royal Philips Electronics
-Safeway, Inc.
-Screening Devices Canada
-SEMOFS
-Sentinel Bioactive Paper Network
-SeraCare Life Sciences
-Serotec
-Siemens Healthcare Diagnostics
-SIENCO
-Smiths Detection
-Smiths Medical MD
-Soar BioDynamics
-Solei Systems, Inc
-Solianis Monitoring
-SpectraScience, Inc.
-Sphere Medical Ltd.
-SpheroSense Technologies
-Stanbio Laboratory
-StatSure Diagnostic Systems
-STD Test Express
-STMicroelectronics
-Synova Healthcare
-Sysmex Corp
-T2 Biosystems
-Taidoc Technology
-TelCare
-Telus Corporation
-Textronics, Inc.
-Thermo Fisher Scientific
-Tosoh Corp
-Trinity Biotech
-TwistDx, Ltd.
-Tyrian Diagnostics
-UnitedHealth Group
-Veralight, Inc.
-Veredus Laboratories
-VeriChip Corporation
-Via Medical Corp
-Vital Diagnostics
-Vivacta Limited
-Walgreens
-Wal-Mart Stores
-Webahn Inc.
-Ypsomed